Patients with gestational diabetes at increased risk of total and CVD related mortality: JAMA

Written By :  Dr. Kamal Kant Kohli
Published On 2023-09-25 03:45 GMT   |   Update On 2023-09-25 06:39 GMT
Advertisement

USA: Findings from a recent study published in JAMA Internal Medicine have found an elevated risk of total and cardiovascular disease mortality in participants with gestational diabetes. 

The researchers revealed that participants who reported a history of gestational diabetes showed a small but increased risk of subsequent mortality over 30 years. The findings stress the importance of considering gestational diabetes as a critical factor in later-life mortality risk.

Advertisement

Gestational diabetes, a condition occurring during pregnancy, has long been associated with various health concerns. The study by Yi-Xin Wang and colleagues, spanning three decades and involving over 90,000 parous participants, sheds light on its long-term impact. The study, conducted among female nurses aged 25 to 42 in the United States, explores the connections between gestational diabetes and both overall and cause-specific mortality.

The study included 91,426 parous participants, with a mean age of 34.9 years and an average body mass index (BMI) of 24.1 at the beginning of the study in 1989. The study followed these participants for a remarkable 30 years, accumulating a total of 2,609,753 person-years of data. Over the course of the study, 3,937 deaths were recorded. Among these, 255 were due to cardiovascular disease, and 1,397 were attributed to cancer.

● Participants with a history of gestational diabetes exhibited a higher crude mortality rate than those without this history, with 1.74 vs. 1.49 deaths per 1,000 person-years, respectively.

● The hazard ratio (HR) for total mortality among those with gestational diabetes was 1.28 (95% CI, 1.13-1.44).

● After adjusting for potential confounding factors and lifestyle choices during the reproductive years, this risk remained elevated, with an HR of 1.25 (95% CI, 1.11-1.41).

● The association persisted even when considering subsequent development of type 2 diabetes and was particularly pronounced in individuals who led less healthy lifestyles.

● Those who experienced gestational diabetes in two or more pregnancies, or in both initial and subsequent pregnancies, had notably higher HRs.

● Concurrent conditions during pregnancy, such as hypertensive disorders, preterm birth, or low birth weight, also intensified the association.

● Cause-specific mortality analysis indicated that gestational diabetes was directly linked to an increased risk of cardiovascular disease-related mortality (HR, 1.59; 95% CI, 1.03-2.47).

● Gestational diabetes was inversely associated with cancer mortality (HR, 0.76; 95% CI, 0.59-0.98), but this effect was primarily observed among participants who later developed type 2 diabetes.

This comprehensive cohort study spanning three decades underscores the long-term health implications of gestational diabetes. Participants with a history of gestational diabetes had a slightly elevated risk of mortality over the 30-year study period. This emphasises the importance of recognizing gestational diabetes as a critical factor in assessing later-life mortality risk. These findings could have significant implications for healthcare providers and pregnant individuals, highlighting the need for closer monitoring and long-term follow-up of individuals with a history of gestational diabetes. Preventive measures and lifestyle interventions may also be warranted to mitigate associated risks.

Reference:

Wang, Y.-X., Mitsunami, M., Manson, J. E., Gaskins, A. J., Rich-Edwards, J. W., Wang, L., Zhang, C., & Chavarro, J. E. (2023). Association of gestational diabetes with subsequent long-term risk of mortality. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2023.4401

Tags:    
Article Source : JAMA Internal Medicine

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News